Study Of Tongdu Tiaoshen Moxibustion Combined With Cognitive Behavior Intervention On Post-stroke Mild Cognitive Impairment

Objective:By observing the efficacy and safety of Tongdu Tiaoshen moxibustion combined with cognitive behavior intervention on post-stroke mild cognitive impairment,We want to provide reference for clinical intervention on post-stroke mild cognitive impairment.Method:In this study,a total of 62 patients from our hospital from January 2022 to December2022 who met the criteria were screened,and 31 cases in each group were included in the control group and the experimental group by random number table method,with 1case shedding in the control group and 1 case shedding in the experimental group.Finally,30 cases were included in the control group and the experimental group.Both groups of patients received basic rehabilitation treatment and nursing routine,on this basis,the control group was given simple Tongdu Tiaoshen moxibustion,experimental group was given Tongdu Tiaoshen moxibustion combined with cognitive behavior intervention.The intervention period of both groups was 3 weeks.The Mini-Mental State Examination(MMSE)、Montreal Cognitive Assessment(Mo CA)and modified Barthel index were respectively applied before and after the intervention to evaluate patients and complete data collection.SPSS26.0 was used for statistics and analysis,and P<0.05 was statistically significant.Results:1.No significant differences before treatment in the general information(age,sex,stroke type,education level,MMSE score,modified Barthel index,Mo CA score,etc.)between the two groups(P>0.05),indicating comparability.2.After treatment,MMSE score,Mo CA score and modified Barthel index in 2 groups were improved compared with before treatment(P<0.05).And the experimental group increased more significantly(P<0.05).3.In terms of safety,no adverse reactions occurred in the process of treatment in both groups,showing good safety.Conclusion:The combination of Tongdu Tiaoshen moxibustion with cognitive behavior intervention for post-stroke mild cognitive impairment is safe and effective,worthy of clinical promotion and application.